GenScript is the world leader
in biotechnology reagent and biologics service industry. Established in 2002 in
New Jersey, the company was the first to commercialize gene synthesis and
successfully establish fully integrated capabilities for peptide synthesis,
protein expression and antibody development. GenScript also have
integrated & innovative biologics CDMO platform to accelerate the process
from target to market and drive innovation further to develop therapeutic
antibody and cell therapy platforms. We provide Antibody Discovery, Development
services including GMP plasmid and viral vectors. Our mission is making people and
nature healthier through biotechnology.